baber/WOPTO huggingface dataset:
Patent EP-1446263-B1 (EP)
Inventor: SCHOWALTER LEO J
IPC: B24B37/04
Filed: 2002-11-20
Granted: 2008-12-24
Abstract: According to one aspect of the invention, an improved process for preparing a surface of substrate is provided wherein the surface of the substrate is prepared for a chemical mechanical polishing (CMP) process, the CMP process is performed on the surface of the substrate, and the surface of the substrate is finished to clear the substrate surface of any active ingredients from the CMP process. Also, an improved substrate produced by the method is provided. According to one aspect of the invention, particular polishing materials and procedures may be used that allow for increased quality of AlN substrate surfaces.
Patent EP-1304329-B1 (EP)
Inventor: TAKEMURA MAKOTO
IPC: A61K31/435
Filed: 1996-02-01
Granted: 2008-10-15
Abstract: This invention relates to a N1-(halogenocyclopropyl)-substituted pyridonecarboxylic acid derivative represented by the following formula (I): <CHEM> wherein X<1> is a halogen atom or a hydrogen atom; X<2> is a halogen atom; R<2> is a group represented by the formula (V): <CHEM> provides a heterocyclic compound useful as antibacterial drugs.
Patent EP-1392078-B1 (EP)
Inventor: ZIEGLER HORST PROF DR
IPC: G01D4/00
Filed: 2003-07-22
Granted: 2009-07-01
Abstract: The unidirectional data transmission method involves forming data strings in terminals containing a unique identification number for the relevant terminal in addition to useful data. The terminals each have a different predefined set of different transmission time desired values that are used in succession in a terminal to determine transmission times.
Patent EP-1450431-B1 (EP)
Inventor: VUK CARL THOMAS
IPC: H01M8/24
Filed: 2003-10-30
Granted: 2006-08-30
Abstract: The fuel cell assembly has a pair of fuel cell stacks having different power capacity, which are coupled to respective zones of manifold having coolant, hydrogen and air inlet/outlet ports (46',48',42',40',38',44').
Patent EP-1547646-B1 (EP)
Inventor: DIKEMAN W CARY
IPC: A61M39/24
Filed: 2003-12-22
Granted: 2008-10-08
Abstract: A pressure-actuated valve component for use in IV therapy to control fluid flow through a catheter in opposite infusion and aspiration directions, said valve component comprising: 
a housing including spaced apart intravenous fluid ports and a tapered male fitting that defines one of the ports and is operable to be attached to the catheter, with a fluid passageway extending between the ports to present a passageway axis; and 
a valve body being disposed within the fluid passageway and including a flexible dome-shaped wall that presents a convex surface and an opposite concave surface, with the convex surface facing the infusion direction and the concave surface facing the aspiration direction, 
said dome-shaped wall including a normally closed slit extending between the surfaces and intersecting the passageway axis, 
said dome-shaped wall flexing to open the slit in response to an infusion fluid pressure differential across the wall, wherein the pressure against the concave surface is greater than the pressure against the convex surface, 
said dome-shaped wall flexing to open the slit in response to an aspiration fluid pressure differential across the wall, wherein the pressure against the convex surface is greater than the pressure against the concave surface, 
said valve body including a rib projecting from the concave surface in an orthogonally extending relationship to the slit, 
said slit intersecting said convex surface to form a convex arc having a convex arc length, said slit intersecting said concave surface to form a concave arc having a concave arc length, 
said convex arc length being greater than said concave arc length, with the slit presenting termination ends that are each at an oblique angle relative to the passageway axis.
Patent EP-1333630-B1 (EP)
Inventor: BRAHIM HAMID OULD
IPC: H04L12/56
Filed: 2003-02-05
Granted: 2011-08-10
Abstract: A technique for implementing an automatic port discovery protocol in a virtual private network cross-connect is disclosed. In one particular exemplary embodiment, the technique may be realized by a method comprising the steps of implementing a virtual private cross-connect for supporting a plurality sites associated with at least one virtual private network; providing at least one connection between the virtual private cross-connect and each site; and supporting a combination of at least two of layer-3, layer-2 and layer-1 services. <IMAGE>
Patent EP-1430856-B1 (EP)
Inventor: LEE CHELYNNE NICOLE
IPC: A61F2/36
Filed: 2003-12-12
Granted: 2006-08-02
Abstract: A modular prosthetic knee implant system includes a femoral component (12), a femoral stem (14), a femoral stem collar (18), an augment (60) and a bolt (16). The modular prosthetic knee system can be assembled in different ways. If assembled without the augment, the stem is at a valgus angle. If assembled with the augment, the stem is at a neutral angle. The stem collar has an inferior surface that is angled with respect to its superior surface, and the augment has a superior surface that is angled with respect to its inferior surface. The components also include mating anti-rotation members to fix the relative positions of the members. <IMAGE>
Patent EP-1336391-B1 (EP)
Inventor: CABANIOLS HENRI GEORGES FRANCIS
IPC: A61F2/00
Filed: 2003-02-12
Granted: 2011-12-14
Abstract: The hernial plate comprises a pocket (1) formed from two textile layers (11,12) and expansion means (2) for ensuring the deployment of the pocket. The expansion means are received in a removable manner in the pocket and pass by reversible deformation from a deployed configuration to a compact ball configuration. One of the textile layers has an orifice (100) allowing the withdrawal of the expansion means out of the pocket after deployment of the pocket.
Patent EP-1524793-B1 (EP)
Inventor: MOTTIER DAVID
IPC: H04B1/69
Filed: 2003-10-16
Granted: 2008-11-26
Abstract: The present invention concerns a method of mapping chips of a spread out symbol to sub-channels of a group of sub-channels of a Multi-Carrier transmission channel of a Multi-Carrier transmission network, the spread out symbol being formed by multiplying a data item to be transmitted by elements of a spreading sequence, the mapped chips being further modulated using an orthogonal frequency division multiplexing modulation, each sub-channel of the Multi-Carrier transmission channel being defined by a carrier frequency of the Multi-Carrier transmission channel and a time slot wherein an orthogonal frequency division multiplexing symbol is transmitted, characterised in that the chips are ordered in a predetermined order, the first chip is mapped to a sub-channel and each following chips are mapped to a sub-channel which has the same carrier frequency or the same time slot as the sub-channel of which the previous chip has been mapped to. The method concerns also a method the de-mapping and associated devices. <IMAGE>
Patent EP-1472255-B1 (EP)
Inventor: ADAMS DAVID REGINALD
IPC: A61K31/498
Filed: 2003-01-17
Granted: 2006-03-01
Abstract: L'invention concerne des composés chimiques, ainsi que des sels pharmaceutiquement acceptables, des solvates et des esters de ceux-ci, représentés par la formule (I), dans laquelle R1 à R4 sont tels que définis dans la revendication 1. Les composés selon l'invention peuvent être utilisés sous forme de préparations pharmaceutiques dans le traitement ou la prévention des troubles du système nerveux central, des lésions du systèmes nerveux central, des troubles cardio-vasculaires, des troubles gastro-intestinaux, du diabète, de l'obésité et de l'apnée du sommeil.
Patent EP-1481671-B1 (EP)
Inventor: YAJIMA HIROAKI
IPC: A23L1/30
Filed: 2003-02-14
Granted: 2011-08-31
Abstract: Agents for treating, preventing or ameliorating diseases comprise a peroxisome proliferator-activator receptor activator selected from ketone compounds (I) - (V) or their salts or solvates, a hop extract or a modified hop extract. Agents for treating, preventing or ameliorating diseases comprise a peroxisome proliferator-activator receptor activator selected from ketone compounds of formula (I) - (V) or their salts or solvates, a hop extract or a modified hop extract. [Image] R 1>, R 2>, R 1> 0>, R 1> 9>1-6C alkyl or 2-6C alkenyl; R 3>, R 4>OH, 1-6C alkyl or 2-6C alkenyl; R 5> - R 7>, R 1> 1>, R 1> 2>, R 1> 6> - R 1> 8>H, 1-6C alkyl or 2-6C alkenyl; R 8>, R 9>H, OH, 1-6C alkyl, 2-6C alkenyl, COR 1> 0> or CH(OH)R 1> 0>; R 1> 3>, R 1> 4>OH, 1-6C alkyl, 2-6C alkenyl, COR 1> 0> or CH(OH)R 1> 0>; and provided that R 1> and R 2>, R 8> and R 9> and R 1> 3> and R 1> 4> are not both OH. An independent claim is also included for foods containing the agents. ACTIVITY : Anorectic; Antidiabetic; Antilipemic. In tests, administration of isohumulone at 0.5 weight% in the diet of C57BL/6 mice fed a high fat diet, significantly (by at least 5%) reduced blood cholesterol levels from 2 weeks. MECHANISM OF ACTION : PPAR-Agonist.
Patent EP-1518451-B1 (EP)
Inventor: RIZZO NICHOLAS D
IPC: H01L27/22
Filed: 2003-06-18
Granted: 2008-04-16
Abstract: Shielded electronic integrated circuit apparatus ( 5 ) includes a substrate ( 10 ), with an eletronic integrated circuit ( 15 ) formed thereon, and a dielectric region ( 12 ) positioned on the electronic integrated circuit. The dielectric region and the substrate are substantially surrounded by lower and upper magnetic material regions ( 26, 30 ), deposited using electrochemical deposition, and magnetic material layers on each side ( 32, 34 ). Each of the lower and upper magnetic material regions preferably include a glue layer ( 36, 40 ), a seed layer ( 28, 24 ), and an electrochemically deposited magnetic material layer ( 26, 30 ). Generally, the electrochemically deposited magnetic material layer can be conveniently deposited by electroplating.
Patent EP-1506005-B1 (EP)
Inventor: ELLISON SIOBHAN P
IPC: A61K39/00
Filed: 2003-05-20
Granted: 2011-09-28
Abstract: The invention relates to a method of excysting and growing protozoal oocysts by in vitro tissue culture resulting in production of a continuous culture of merozoites. The invention also provides an economical and reliable supply of cultured Eimeria sp. for vaccine production, assays and research. Domesticated avians that have been vaccinated using the provied Eimeria sp. are also provided.
Patent EP-1518182-B1 (EP)
Inventor: BARASCH STEPHEN
IPC: G01J3/46
Filed: 2003-05-22
Granted: 2011-08-17
Abstract: A method for determining percentages of colors needed to obtain a mixed color is described. The method includes: determining a difference between an expected function and a measured function of a color resulting from mixing a first and second colors; and utilizing the difference to determine percentages of the first and second colors needed for creating the color.
Patent EP-1558800-B1 (EP)
Inventor: WILLIS EDWARD KEITH
IPC: D04H1/54
Filed: 2003-11-05
Granted: 2006-04-26
Abstract: The present invention provides a nonwoven fabric that is especially engineered to function as the substrate for a dryer activated fabric softener sheet. The substrate has a basis weight of 0.48 ounces per square yard or less, a thickness of from about 0.16 mm to about 0.38 mm, and comprises a nonwoven web of fibers, wherein at least some of the fibers are hollow. Preferably the fibers have a denier of from 2 to 8. In preferred embodiments of the invention, the hollow fibers have a void area at least 10 percent of the fiber cross-section, and the fibers have a noncircular trilobal cross-section.
Patent EP-1574229-B1 (EP)
Inventor: MATSUDA SHOJIRO
IPC: A61L27/44
Filed: 2003-12-08
Granted: 2012-06-06
Abstract: 生体適合性および生体吸収性に優れ、かつ、縫合・接着に対する強度に優れる医療用フィルムを提供する。ゼラチン溶解液に生体内分解吸収性高分子製の補強材１２を配置して、前記補強材１２に前記溶解液を浸透させてから、前記ゼラチンを乾燥する。これによって、前記補強材１２内部の全体に浸透したゼラチンがゲル化し、ゼラチンフィルム１１を形成し、前記補強材１２と前記ゼラチンフィルム１１とが一体化した医療用フィルム１となる。前記ゼラチンフィルム１１は、架橋されたゼラチンフィルムであることが好ましい。
Patent EP-1558607-B1 (EP)
Inventor: CAO JINGRONG
IPC: C07D409/14
Filed: 2003-10-30
Granted: 2010-05-05
Abstract: L'invention concerne des dérivés thiazole et thiophène substitués utiles en tant qu'inhibiteurs de rock et d'autres protéines kinases. L'invention concerne également des compositions pharmaceutiquement acceptables comprenant lesdits composés, et des méthodes d'utilisation de ces compositions pour le traitement de maladies, d'états pathologiques ou de troubles variés, notamment des maladies prolifératives, cardiaques et neurodégénératives.
Patent EP-1529302-B1 (EP)
Inventor: ROESNER NORBERT
IPC: H01H71/08
Filed: 2003-08-07
Granted: 2006-04-12
Abstract: The switching device has an insulating housing (2), each switch pole having incoming and outgoing contacts (4) provided with respective terminals (41) for connection with an external electrical lead, at least one of the contacts having a second terminal (42) for connection with a second electrical conductor, positioned between its opposite ends, respectively provided with the first external electrical lead terminal and a stationary switch contact (43). Each second terminal can be provided by an opening for reception of an electrical conductor pin contact.
Patent EP-1532184-B1 (EP)
Inventor: BAUMEISTER MANFRED
IPC: D21H19/00
Filed: 2003-07-25
Granted: 2006-05-03
Abstract: Graft copolymers (I) derived from proteins, grafted with ethylenically unsaturated monomers containing amide and/or amino groups and partly crosslinked with a polyfunctional epoxide and/or a polyfunctional aziridine and/or trichloro-triazine and/or dichloride-hydroxy-triazine.  An Independent claim is also included for coating materials for printable paper in the form of aqueous dispersions with a solids content of 50-80 wt%, containing pigments, auxiliary materials and (I).
Patent EP-1468812-B1 (EP)
Inventor: CEVOLINI FRANCO
IPC: B29C67/00
Filed: 2004-03-30
Granted: 2011-11-23
Abstract: A mixture of sinterable powders for rapid prototyping, comprising a powdered polymer base and material of a substantially glassy type in the form of microflakes, optionally with the addition of a material of a substantially glassy type in the form of microspheres, powdered aluminum and/or powdered graphite.
Patent EP-1470829-B1 (EP)
Inventor: VOGT SEBASTIAN DR
IPC: A61L27/00
Filed: 2004-04-01
Granted: 2007-11-14
Abstract: Porous articles (A) having an antibiotic coating, where a coating of a salt (I) of fusidic acid (FA) with antibiotic (AB) is applied to the pore system of a non-metallic and/or metallic article, (I) being sparingly soluble in water or aqueous media and AB being gentamicin, sisomycin, netilmycin, streptomycin, tobramycin, spectinomycin, vancomycin, ciprofloxacin, moxifloxacin, clindamycin, lincomycin, tetracycline, chlorotetracycline, oxytetracycline or rolitetracycline. An independent claim is also included for the preparation of (A), by applying an aqueous solution of soluble salt(s) of AB to the pore system of the porous articles, then applying an aqueous solution of a sparingly soluble salt of FA to form (I) in the pore system; alternatively the order of the steps may be reversed.
Patent EP-1511264-B1 (EP)
Inventor: LUND SIGURD ANDRE
IPC: H04L27/36
Filed: 2004-08-19
Granted: 2010-03-31
Abstract: A method or arrangement for optimising the performance of a modulator arranged to output a complex signal including the steps of determining an area confined by an upper part of an amplitude density curve of said complex signal, and of adjusting at least one modulation impairment factor for minimizing said area. The invention allows improvements in modulation of the complex signal with simpler and less costly hardware than previously known solutions. <IMAGE>
Patent EP-1643804-B1 (EP)
Title: Air heater
Inventor: GISLER-REINHARD LUKAS
IPC: H05B3/06
Filed: 2004-09-29
Granted: 2007-01-03
Abstract: The heater has contact pins (16) that are placed in a receptacle angle bracket of a connecting housing. The pins are electrically insulated from the housing. The pins are connected with a connection board by rubber-elastic connecting units (1) located in a U-shaped support shell of the angle bracket. The pins are connected with electrical contact tracks of the board for the purpose of transmitting signals to a control device.
Patent EP-1491733-B1 (EP)
Inventor: PANCIROLI MARCO
IPC: F01L9/10
Filed: 2004-06-21
Granted: 2007-04-25
Abstract: The method involves moving components between two positions, where each component transmits vibrations at a location of one of end positions of the component during operation of an internal combustion engine (M). A signal correlated with these vibrations is acquired. The signal is correlated with impact energy determined by an impact of the components against an abutment disposed in one of these end positions. An independent claim is also included for a control device for an internal combustion engine.
Patent EP-1599878-B1 (EP)
Inventor: LEHMANN URS
IPC: G11B7/257
Filed: 2004-02-23
Granted: 2006-06-07
Abstract: The invention relates to an optical recording medium comprising a substrate, a reflecting layer and a recording layer based on compounds of formula (I) wherein G<SUB>1 </SUB>and G<SUB>2 </SUB>are each independently of the other, A<SUB>1 </SUB>and A<SUB>2 </SUB>are each independently of the other N(R<SUB>12</SUB>), O, S or Se and A<SUB>3 </SUB>is C(C<SUB>1</SUB>-C<SUB>5</SUB>alkyI)<SUB>2</SUB>, C(C<SUB>4</SUB>-C<SUB>5 </SUB>alkylene), N(R<SUB>12</SUB>), O, S, Se, N-C(R<SUB>13</SUB>) or unsubstituted or R<SUB>14</SUB>-substituted CH-CH; M<SUB>1 </SUB>is a transition metal of groups (IX) to (XIII), preferably Co, Cu, Ni, Pd or Zn, especially Co, Cu or Ni; Q<SUB>1 </SUB>and Q<SUB>2 </SUB>are each independently of the other C(R<SUB>15</SUB>), N or P, . . . For the detailed definitions of the further substituents, see the description. Recording and playback are effected especially at a wavelength of from 350 to 500 nm, for example using a blue laser. The recording and playback quality is excellent and allows a high storage density. Also claimed are new compounds of formula (I), with the exception of the compounds disclosed in J. Org. Chem. 67/16, 5753-5772 [2002].
Patent EP-1599225-B1 (EP)
Inventor: PLUSCHKE GERD
IPC: A61P33/06
Filed: 2004-03-03
Granted: 2007-05-16
Abstract: The invention presents vaccine formulations comprising highly antigenic epitopes identified within the semi-conserved loop-I of domain III that are capable of eliciting parasite growth inhibitory antibodies. The cyclized or linear peptides can be applied by known adjuvants or be encapsulated by or attached onto the surface of liposomes or virosomes (IRIVs) which serve as human compatible antigen delivery systems. Both cyclized and linear versions of the peptide antigens are surprisingly effective in eliciting immune responses that are cross-reactive with parasite-expressed AMA-1.
Patent EP-1609858-B1 (EP)
Inventor: ENDOU HITOSHI
IPC: C07K16/18
Filed: 2004-03-05
Granted: 2009-01-14
Abstract: It is intended to provide novel amino acid transporters which act as a single molecule and transport neutral amino acids typified by branched amino acids, and genes thereof. A protein consisting of an amino acid sequence represented by SEQ ID NO:2, 4, 6 or 8 or an amino acid sequence derived from an amino acid sequence represented by SEQ ID No:2, 4, 6 or 8 by deletion, substitution or addition of one to several amino acids, and being capable of sodium-independently transporting neutral amino aicds typified by branched amino acids and analogs thereof as a single molecule. A gene which is a DNA consisting of a base sequence represented by SEQ ID NO:1, 3, 5 or 7 or a DNA hybridizable with it and encodes a protein capable of sodium-independently transporting branched amino acids as a single molecule.
Patent EP-1636263-B1 (EP)
Inventor: SEEGERT DIRK
IPC: C07K14/705
Filed: 2004-06-23
Granted: 2007-08-15
Abstract: A polypeptide dimer (I) comprises two soluble glycoprotein (gp) 130 molecules, where at least one of the gp130 molecules is covalently linked to polyethylene glycol (PEG). Independent claims are also included for: (1) a polynucleotide (II) encoding (I) or a monomer of (I); (2) an expression vector (III) containing (II); (3) a host cell (IV) containing (III); (4) producing (I); and (5) pharmaceutical composition (V) containing (I). ACTIVITY : Osteopathic; Cardiovascular-Gen.; CNS-Gen.; Gastrointestinal-Gen.; Immunomodulator; Cytostatic; Immunosuppressive; Antiinflammatory; Antibacterial; Virucide. MECHANISM OF ACTION : Calcium antagonist; Inhibitor of interleukin-6 (IL-6)/soluble IL-6 receptor (sIL6R) complex. Lamina propria mononuclear cells (LPMC) were cultured in complete medium consisting of RPMI-1640 with 3 mM L-glutamine, 10 mM HEPES buffer, 10 Microg/ml gentamycin, 100 U/ml penicillin, 100 U/ml streptomycin, 50 MicroM 2-mercaptoethanol and 10% heat-inactivated FCS. Cells were stimulated with 10 Microg/ml C reactive protein, 50 ng/ml phorbol-12-myristate-13-acetate (PMA) and 10 Microg/ml phytohaemagglutinin (PHA) in the presence or absence of sgp130Fc, neutralizing IL-6R specific antibody or sgp130PEG. After 48 hours cells were stained with Annexin V and propidium iodide and analyzed by fluorescence activated cell sorting (FACS). Unreacted samples contained approximately 60% apoptotic cells whereas treatment with anti-IL-6 antibody, sgp130Fc or sgp130PEG resulted in an increase of apoptotic cells between 11-16%. Similarly, the ability of sgp130PEG to inhibit IL-6/IL-6R dependent proliferation of BAF/3 cells and IL-6 induced signal transducer and activator of transcription (STAT3) activation in BAF/gp130 cells was studied. The results showed that the sgp130PEG treatment inhibited IL-6/IL-6R dependent proliferation of BAF/3 cells at a factor of 1.5-3 compared to sgp130Fc, and reduced the STAT3 activity with approximately 2-3 fold higher efficiency than sgp130Fc.
Patent EP-1654908-B1 (EP)
Inventor: CORYNEN DAVID M E
IPC: H04R9/04
Filed: 2004-08-03
Granted: 2007-03-21
Abstract: A loudspeaker provided with a frame (101), a membrane (103) and a drive unit (105). The membrane has an outer circumferential edge (104a) suspended from the frame and an inner circumferential edge (104b). The drive unit has a stationary part (106a) secured to the frame and a translatable part (106b) provided with a coil support (108b) secured to the inner circumferential edge of the membrane. The membrane includes a membrane body (104) which, viewed in a circumferential direction, has a pattern of folds radially extending between the inner circumferential edge and the flat outer circumferential edge of the membrane. The folds have a depth (d), which increases from the edges (104a, 104b) towards an area (104A) situated between both edges. In this area, the folds are provided with faces (204C), to which a spider (111) of the loudspeaker is secured. This loudspeaker combines a small height with a large stroke of the membrane.
Patent EP-1637553-B1 (EP)
Inventor: KITAHARA YOSHITAKA
IPC: G02B1/04
Filed: 2004-06-09
Granted: 2009-11-25
Abstract: A transparent molded article comprised of polythiourethane obtained by polymerizing monomer components comprising the following component (A) and component (B1). A transparent molded article obtained by polymerizing monomer components comprising the following component (A), component (B1), component (B2) and component (C). 
Component (A): one or more polythiol compound denoted by general formula (I)   
(In general formula (I), m is 1, 2, 3, 4, 5 or 6.) 
Component (B1): one or more polyisocyanate compound denoted by general formula (II)   
(In general formula (II), n 1 , n 2  and n 3  are each independently 3, 4, 5, 6, 7 or 8.) 
Component (B2): one or more aliphatic diisocyanate compound having an intramolecular cyclic structure 
Component (C): aliphatic diol compound
Patent EP-1632768-B1 (EP)
Inventor: DEREVYAGIN ALEXANDR MIKHAILOVICH
IPC: G01B11/06
Filed: 2004-05-25
Granted: 2011-10-12
Abstract: The invention relates to measuring engineering. In order to increase accuracy by increasing sensitivity, for the inventive dew point measurement method a light flux polarised in the plane of incidence thereof is used and directed towards the condensation surface of a dielectric cooled element at an angle at which the light flux is not reflected from the condensation surface of the cooled element in the absence of condensate.